Actively Recruiting
Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI
Led by GramEye · Updated on 2024-07-26
10000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
G
GramEye
Lead Sponsor
O
Osaka University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This observational study aims to develop artificial intelligence (AI) technology that can detect and classify Acid-Fast Bacilli (AFB) in microscope images. The AI will be trained and evaluated using anonymized and fixed glass slides to improve rapid bacterial species identification related to bacterial infections. The research is sponsored by GramEye and focuses on enhancing diagnostic accuracy for these infections. The study does not involve treatments or interventions but collects microscope images of AFB smears to develop and assess the AI system. There are no study groups or drug therapies involved. The AI's performance will be compared to actual culture results to measure agreement in detecting the presence or absence of acid-fast bacteria. Participants are patients who have had an AFB smear test ordered. Researchers will analyze microscope images from these patients without impacting their usual care. The main outcome measured is how well the AI's results match actual culture findings on day one. There are no additional tests or follow-ups required, and participation involves only data collection from existing samples.
CONDITIONS
Brief Title
Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients in whom acid-fast bacilli(AFB) smear test was ordered
You will not qualify if you...
- No exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo acid-fast bacilli smear tests and AI-based image analysis to identify bacterial species.
1 visit (in-person)
Duration - Up to 6 months
Participants are observed to compare AI-estimated results with actual culture results regarding the presence or absence of acid-fast bacteria.
Additional visits as needed for culture results
Trial Site Locations
Total: 1 location
1
Osaka University Hospital
Suita, Osaka, Japan, 5650871
Actively Recruiting
Research Team
T
Tatsuya Yamada, M.D.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here